Non-Invasive Prenatal Testing Market in Europe Remains Lucrative with Surged Preferences for Non-Invasive Diagnosis

Published on : Jan 09, 2019

Albany, New York, January 9, 2019: Governed by high prevalence of Down syndrome besides other macroeconomic determinants such as better reimbursement policies, improved healthcare infrastructure, and growing preferences for non-invasive test mechanisms, the European non-invasive prenatal testing market is estimated to record exponential growth ratios.

Besides aforementioned factors, growing number of pregnant women on the higher side of maternal age has also been a major growth facilitator in non-invasive prenatal testing market in Europe. Such pivotal market highlights have been gleaned in Market Research Hub's (MRH) recent business intelligence report titled, 'Europe Non-Invasive Prenatal Testing Market Research Report 2018' collated in its voluminous online database.

Premathia and Illumina Ink Partnering Deals for Novel Tests across Europe

The competitive landscape of non-invasive prenatal testing market in Europe is characterized by globally established market players as well as aspiring vendors operating at the regional level. Advances in developing of cutting-edge technology to remain industry specific in their offerings is crucial amongst leading providers. Additionally, strategic acquisitions and mergers also remain staple growth strategies embraced by leading manufacturers. In a recent development, leading providers of non-invasive prenatal tests in Europe, Premaitha have entered into a coalition agreement. According to the terms of the agreement Premaitha will work on Illumina's NIPT patent pool to carry out testing across Europe against royalties to be paid to Illumina.

European Non-Invasive Prenatal Testing Market: Overview

The report includes a granular overview of various market facets that influence growth in non-invasive pre-natal testing market in Europe. The report offers a coherent analysis of market size in terms of both present and historic figures to determine accurate forecast estimations. Commencing with a detailed market definition the report houses pertinent details on market dynamics such as drivers, restraints, challenges, and opportunities that influence growth in non-invasive pre-natal testing market in Europe. To aid market players' investment discretion the report in its subsequent sections identifies test type as the lone segment in non-invasive prenatal testing market in Europe. Also, the report includes a systematic regional segmentation highlighting potential marketing strategies implemented by leading market players across these regions.

Competition Dashboard: Europe Non-Invasive Prenatal Testing Market

In the concluding sections the report offers decisive insights on key players operational in Europe with complete cues on crucial parameters comprising company overview, product portfolio, market revenue, and other vital developments. A thorough analysis of these relevant information by established as well as aspiring market players allow them to decipher core deductions based on which market players can deliver lucrative business decisions. Some of the leading players include, Ariosa Diagnostics (Roche), LifeCodexx AG, Premaitha Health PLC and NIPD Genetics.

Request a Sample with TOC in a PDF format :

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top